Adverse effects of iron toward the peritoneal mesothelial cells are reversible

Ther Apher Dial. 2022 Dec;26(6):1247-1255. doi: 10.1111/1744-9987.13797. Epub 2022 Jan 18.

Abstract

Introduction: Evaluation of the effects of the drugs used for iron supplementation on the peritoneal mesothelial cells.

Methods: Acute effects during18-h incubation of iron sucrose, ferric carboxymaltose, and iron isomaltoside in concentrations 1, 5, and 20 ug/dl on properties of the human peritoneal mesothelial cells in in vitro culture were evaluated, and their reversibility after the following culture for 14 days in the iron-free medium was studied.

Results: All studied compounds reduced viability of mesothelial cells and proliferation rate and increased intracellular oxidative stress and iron content in the cytosol. Secretion of monocyte chemoattractant protein-1 was increased and tissue plasminogen activator (t-PA) decreased. After 14 days of culture in iron-free medium, reversibility of all these effects was observed.

Conclusion: Iron compounds impair the functional properties of mesothelial cells in a dose-dependent manner, but these effects are reversible after the following culture of the cells in an iron-free medium.

MeSH terms

  • Cells, Cultured
  • Epithelial Cells* / physiology
  • Ferric Oxide, Saccharated / pharmacology
  • Humans
  • Tissue Plasminogen Activator* / pharmacology

Substances

  • Tissue Plasminogen Activator
  • Ferric Oxide, Saccharated